Physiology of the Parathyroid Glands I will not discuss here the factors which influence the production from the gland of parathyroid hormone, or parathormone. Suffice it to say that the evidence for participation of the pituitary is fragmentary and is at least of no clinical importance. The function of the parathyroid gland is, however, closely concerned with the blood calcium level, both its size and its hormone production being increased when the blood calcium is low and decreased when it is high. These facts seem to be beyond dispute. The evidence that it is also influenced (in the opposite sense) by the blood phosphate level is at the moment ambiguous.
DISCUSSION ON THE PHYSIOLOGY AND CLINICAL DISORDERS OF THE PARATHYROID GLANDS Dr. C. E. Dent: Physiology of the Parathyroid Glands I will not discuss here the factors which influence the production from the gland of parathyroid hormone, or parathormone. Suffice it to say that the evidence for participation of the pituitary is fragmentary and is at least of no clinical importance. The function of the parathyroid gland is, however, closely concerned with the blood calcium level, both its size and its hormone production being increased when the blood calcium is low and decreased when it is high. These facts seem to be beyond dispute. The evidence that it is also influenced (in the opposite sense) by the blood phosphate level is at the moment ambiguous.
The nature of the peripheral action of parathormone has attracted a great deal of attention, since this is closely concerned with a clinical matter of interest and importance, namely, the very difficult but rewarding problem of making a firm diagnosis of hyperparathyroidism. It is with this that I will concern myself. I will mention first the two main theories concerned with the alleged primary action of parathormone and then produce some destructive criticism of one. I will end with a description of a compromise scheme.
The first theory was proposed by Collip et al. (1925) who based their views on the histological findings in the bone in cases of hyperparathyroidism. They believed simply that the primary action of parathormone was on bone, that it caused a stimulation and multiplication of osteoclasts, and that the ensuing resorption of bone liberated the contained calcium and phosphorus (as phosphate) into the circulation. The ensuing changes in blood electrolyte levels were all supposed to be secondary to the bone changes. This theory explains well the raised blood calcium levels which are so characteristic of the disease, and the tendency to ectopic calcification, due presumably to oversaturation of body fluids with calcium phosphate. It does not explain the low blood phosphate levels that are always found in hyperparathyroidism in the absence of secondary renal disease. Albright and Reifenstein (1948) have been the main supporters recently of the alternative theory that the primary action was on the kidney and that any action on bone was of less importance. It is easier to understand this viewpoint if it is seen against the background of Albright's main clinical contribution in this field. This is the fact he has so repeatedly stressed that hyperparathyroidism, although originally described as a severe disease of bone, could also occur in the absence of any demonstrable bone changes. Indeed these cases, which usually presented with renal damage or stones, were much commoner than the others. The diagnosis had then to be made purely by biochemical means; determinations of blood levels, urinary excretion and so forth. Clearly the important part played by the kidney in such circumstances would have to be emphasized. Albright has attached a great deal of importance to the findings of Ellsworth and Howard (1934) , which he subsequently confirmed and extended, on the immediate changes taking place in blood and urine after a single intravenous injection of 200 lISP units of parathyroid extract. These findings were that there was at once an increa3ed excretion of phosphate, followed by a fall in serum phosphate. This could only be interpreted as an increased clearance of phosphate by the kidney. The rises in serum and urine calcium levels only followed after some hours, and were therefore considered to be the result of the changes in phosphate levels. This is the weak point of the argument since Albright could only attempt this correlation by invoking the mysterious, but undoubtedly real, calciumphosphorus product mechanism. He argued that this mechanism was stimulated by the fall in serum phosphate and that the bone was dissolved in order to provide the extra calcium required to raise the blood level in the expected compensatory fashion. Once this hurdle was crossed the rest was straightforward enough. The raised serum calcium produced a large urinary excretion and its maintenance necessitated continuous bone dissolution. Whether or not the patient got frank osteitis fibrosa depended on whether his calcium intake was adequate to compensate for the large continued loss in the urine. Note here that Albright, unlike anybody else, has made a serious attempt to explain the fact that hyperparathyroidism may or may not be associated with demonstrable bone disease.
APRIL- ENDOCRIN. 1 The essential features of his scheme are summarized diagrammatically in Fig. 1. Note that it comprises a chain of events following each other, and that if one link of the chain is broken the whole scheme must fall to the ground. Albright. I will now mention some unpublished work with my collaborators Dr. A. D. Kenny and Mr. G. Philpot, in which we have repeated the parathormone test of Ellsworth and Howard. We have used several batches of the hormone from the two 1.S. manufacturers, Eli Lilly and Parke Davis. We had two good opportunities to confirm that their hormone was active in raising the plasma calcium level in patients with post-operative hypoparathyroidism. In 20 tests on 15 subjects (mostly normals) however, the hormone produced hardly any increase in phosphate excretion. The effect was slight if present at all. Our results closely paralleled those of Milne (1951). One hypoparathyroid patient likewise showed no effect, two others showed about threefold increases only. The plasma changes were interesting. There was an almost invariable slight rise in calcium level, thus confirming the activity of the hormone preparation. The phosphate level, however, only fell convincingly when it was already high to begin with; when it was normal, the changes were variable and insignificant. Our conclusions from this work are as follows: Firstly, the phosphate excretion effect of parathormone is insignificant in the modem preparations used of active hormone assayed as usual on the basis of its calcium raising power. Secondly, its variability in action in our hands as compared with the results of others suggests that the phosphate excretion effect when present is due to a different factor from that responsible for calcium raising. This could either be an artefact or the real action of a second parathyroid hormone. Finally, whatever the explanation of our results we believe that they weaken the Albright theory which has been so firmly based on the Ellsworth-Howard test as originally performed.
We have also attempted recently a further test of the Albright theory which is part of a programme of investigation into the calcium-phosphorus product mechanism. Briefly, we have reduced plasma phosphate levels by means of oral aluminium hydroxide and looked for any ensuing changes in calcium levels. We argued that if the Albright theory were correct a fall in plasma phosphate produced by any means should, other things being equal, provoke the calcium-phosphorus product mechanism as from stage 2 of Fig. 1 and lead to the same consequences from then on as occur after an injection of parathormone. This however did not occur. The plasma calcium did not change significantly. We have only done this three times, but the experiments were carefully controlled and the results are we believe significant.
There is also a great deal of experimental evidence indicating that parathormone can act on bone and produce the blood electrolyte changes equally well in the absence of the kidney. This work has been reviewed most impartially by Albright and Reifenstein (1948) in their classic textbook. Stewart and Bowen (1951) have shown this more recently in especially well conceived experiments.
There is also some clinical evidence that the plasma calcium level is more closely related to the action of parathormone than the phosphate level. This can be shown by plotting the levels in patients for a period before and after removal of a parathyroid adenoma. It is easily seen that the raised calcium level falls at once after the operation, usually being normal or subnormal within three to four days.
The rise in phosphate is usually much slower and is more unconvincing. It is undoubtedly this closer relation to calcium metabolism which has biased clinical diagnostic methods towards a study of calcium levels and urinary excretions, rather than of phosphate. Likewise in the assay of parathyroid extracts it is the calcium raising power which has always been used as the criterion of parathormone content, and attempts to assay it by its phosphate excretion effects have been generally rejected. Barnicot (1948) has also shown a direct dissolving action on bone of a piece of parathyroid tissue grafted in close proximity to it.
There is also much armchair criticism that can be levelled at any theory that is exclusively or mainly based on a renal action. For instance, if the blood electrolyte levels cause the bone changes then there should be a correlation between blood levels and the two main clinical types of hyperparathyroidism, namely, that with and that without demonstrable bone changes. Not only is this not so but the electrolyte changes in both cases tend to be most inconsistent (hence the difficulties in diagnosis). In cases with renal disease, for instance, the blood phosphate may be normal or even raised; this should reverse Albright's scheme ( Fig. 1 ) and lead to a phase of recovery of the bone disease. That this is not so is well shown in primary renal disease with secondary hyperparathyroidism where identical bone changes may occur even though the kidney has never been able to react in the desired fashion. It is also difficult to explain on a renal basis the oversaturation of the body fluids with calcium phosphate that is known to occur. If calcium phosphate dissolves out of bone, as Albright suggests, to maintain a disturbed calcium-phosphorus product, the result should be osteomalacia and not osteitis fibrosa.
In spite of the above criticisms of a primary renal action, the writer believes that a renal action exists and that this action is indeed, as Albright states, concerned with increasing phosphate clearance by the kidney. Only in this way can the low plasma phosphate levels so characteristic of uncomplicated hyperparathyroidism be accounted for. It is probably not just due to a direct action on the kidney of the raised calcium level consequent on osteoclastic bone resorption since a low phosphate is not usually found with the raised calcium when rapid resorption is taking place under other circumstances, e.g. after sudden immobilization or in the presence of widespread secondary carcinoma. The renal action is better considered as less important than its primary action which is that on bone. It is easier to conceive it as a teleological mechanism for lowering the calcium-phosphorus product and hence the tendency to ectopic calcification in the presence of a raised plasma calcium. It must be stressed that this secondary action is quite independent of the primary bone action since in the presence of renal damage only the latter can and does operate.
The appended scheme (Fig. 2 Martin and Perkins' (1951) recent contribution concerning the calcium binding power of serum albumin in cases of hyperparathyroidism. It is stressed that the main problem at the moment is the preparation of a really pure hormone (or hormones). It is unfortunate that so little has been done recently in this direction. Until this is achieved, experimental work using the crude preparation will remain under suspicion and we will continue to be largely dependent on studies taken as opportunity offers from clinical material. REFERENCES ALBRIGHT, F. A., and REIFENSTEN, E. C. (1948) The Parathyroid Gland and Metabolic Bone Disease. London. BARNICOT, N. A. (1948) Hyperparathyroidism The Effects ofExcessive Parathyroid Activity (see Fig. 1) (1) On the kidney and blood.-According to Albright the primary site of parathyroid activity is on the excretion of phosphates by the renal tubules. Excessive activity leads to relative failure to reabsorb phosphate. This gives rise to excessive excretion of phosphate in the urine. The level of inorganic phosphate in the blood therefore diminishes. A homeostatic constancy in the product of phosphate and calcium is maintained whenever possible, and consequently as the phosphate level drops the serum calcium level rises. The first reaction to this excess of blood calcium is to excrete it through the kidney. This constitutes the "biochemical syndrome" of hyperparathyroidism, namely phosphaturia, low serum phosphate, hypercalcemia, and excessive excretion of calcium in the urine. This, in itself, is almost diagnostic of hyperparathyroidism. Theoretically this biochemical syndrome could be established without any pathological or clinical manifestations, and if the condition were corrected at this stage, no harm would be done. It is however almost impossible to detect the metabolic deviation during this phase.
What happens next depends to some extent on how much calcium is available from other sources to maintain the high serum calcium level which is required to compensate for the low inorganic phosphate level in the blood. If the diet contains reasonable quantities of calcium it is, at this stage, unnecessary to call upon the calcium reserves in bone. Calcium continues therefore to be maintained at high levels in the blood, and to be excreted in large quantities by the kidney. Sooner or kIter this must lead to pathological changes in the kidney. Calcium becomes deposited in the collecting tubules and gives rise to nephrocakinosis or else renal calculi are formed-nephrolithiasis. In any case the effort to excrete such excessive amounts of calcium leads to polyuria, because additional quantities of water need to be excreted, and this in turn produces thirst-"cakium diabetes". Indeed at this stage the erroneous diagnosis of diabetes insipidus is often made. During this phase the patient may also complain of a variety of non-specific symptoms such as excessive fatigue, muscular weakness, anorexia, vomiting, constipation, and may be found to suffer from peptic ulceration. These are all probably due to the effect of the high serum calcium level causing atony of skeletal' and smooth muscle. This constitutes the "renal syndrome". It may progress and produce sinister and irreversible effects which will eventually cost the patient his life, without any of the so-called classical bone lesions of hyperparathyroidism. This phase of the disease has been labelled " hyperparathyroidism-without-bone-disease" by Fuller Albright. However excusable it may be to fail to recognize the symptomless "biochemical syndrome"-and in these days of exhaustive laboratory investigations one might make a good case for routine serum calcium estimations where the presenting symptoms of fatigue and vague digestive disturbances tax the diagnostic acumen of the clinician-the existence of renal stones should provide the necessary clue. 5 per cent of all cases of renal calculi at the Massachusetts General Hospital were associated with hyperparathyroidism, and if all physicians, surgeons and genito-urinary surgeons would insist on a serum calcium estimation in all cases of renal stone the incidence of associated hyperparathyroidism might well be found to be much greater. The importance of this cannot be too strongly emphasized. The prime cause of death in cases of hyperparathyroidism is renal failure, and the prognosis of any individual case depends on how soon the renal condition is recognized and treated.
(2) On the bone.-Hyperparathyroidism-with-bone-disease sometimes follows, and is sometimes superimposed upon the renal phase of the condition. It largely depends on the calcium intake and this may be determined by the actual concentration of the calcium in the diet, or the efficiency of calcium absorption from the gut. If adequate supplies of calcium are not available from the gut then other sources, such as bone, are called upon to supply the calcium to maintain the artificially high levels of serum calcium, demanded by 'the constant drain on the serum inorganic phosphate. It would perhaps be misleading to insist that it is extracted from bone only when all other sources of calcium have been exhausted. The two opposing theories of parathyroid function have now been partially reconciled. Albright, who maintained -that the action of the parathyroid hormone was on the tubular re'absorption of phosphate, and Collip, who believed that it was concerned with the mobilization of calcium from bone, have compromised their differences, and we are now asked to believe that the hormone has two functions-to control the urinary excretion of phosphate, and accelerate the turn-over of bone formation. We may suppose that sometimes this function is secondary to the renal function, so that in some cases the renal syndrome antedates the "osseous syndrome". In other cases these functions are manifested simultaneously and bone lesions occur early in the disease. It would appear that the normal action of the hormone is to regulate the rate of bone formation-to control the rate of bone deposition by the osteoblasts, and of bone resorption by the osteoclasts; but over-activity of the hormone seems to accelerate the process in such a way PARATHYROIDS 0 0~~~0 11 . Hyperparathyroidism leads to mobilization of calcium from bone and 12. Osteoclastoma. 13. Bone rarefaction leads to compensatory osteoblastic activity, accompanied by 14. Raised serurn phosphatase. Excessive osteoblastic activity may lead to 15. Metastatic calcification. that bone resorption exceeds bone deposition. There is evidence of the prominence of osteoclasts in the osteoclastomata, or giant-cell tumours of the skull, and other bones. There is evidence of inability to maintain the normal bone structure, and areas become fibrous, instead of bony: osteitis fibrosa. Some areas actually become cystic. The weakened bony structure bends easily and all sorts of bizarre deformities consequently occur. Spontaneous fractures are readily produced, and the classical appearance of osteitis fibrosa cystica generalisata (von Recklinghausen's disease) develops. Certain manifestations are almost pathognomonic of hyperparathyroidism. They are (1) The "moth-eaten" appearance of the skull. (2) The subperiosteal bone resorption, which is found characteristically in the phalanges, and (3) the absence of the lamina dura of the teeth. But, although this evidence of bone resorption is so prominent one must not forget that there is a constant attempt to catch up with it by increased deposition of bone. There is marked increase in the activity of the osteoblasts which is manifested by a raised level of alkaline serum phosphatase, which completes the biochemical syndrome of hyperparathyroidism. Thus, though it may be difficult to detect clinically the biochemical syndrome, or the renal syndrome, it should not be difficult to identify the osseous syndrome, and immediate treatment is called for.
Treatment.-Surgery is the only possible form of treatment. 80% of parathyroid adenomas are found in the region of the thyroid, but if the adenoma arises in one of the inferior parathyroid glands, the anlage of which arises from the third branchial cleft, the gland may migrate downwards with the thymus-it is sometimes known as the "parathymic gland"-and end up anywhere in the anterior mediastinum. It may be necessary therefore to split the sternum and explore the mediastinum to find the adenoma. If the diagnosis has been confidently made before operation the surgeon must pledge himself to find the adenoma. As Albright says "a good thyroid surgeon is not enough. The finding of a parathyroid tumour may be very simple or very difficult. The operation should not be undertaken by a surgeon who has not made a special study of the appearance and location of normal parathyroid glands, of their differentiation from small lymph nodes and collections of fat, &c. Much mischief has been done by the 'let's-have-a-look' approach to the problem. There is no time like the first operation to uncover a small adenoma. Once the neck is filled with scar tissue, the problem becomes more difficult. As in all surgery the second fifty operations for any operator are much simpler than the first." Occasionally the pathological condition is found to consist of diffuse hypertrophy and hyperplasia of all four glands instead of an adenoma of one gland. In such a case partial resection should be performed leaving 30-200 mg. of hyperplastic tissue.
Post-operative tetany may occur, especially if bony changes are prominent and there is a high alkaline phosphatase level, for it is usually due to the avidity of the decalcified skeleton for calcium-"hungry bones" tetany. Rienhoff of Baltimore recommends transplanting a portion of the adenoma into the thyroid or the sternomastoid muscle to prevent tetany in this type of case.
Hypertrophy and Hyperplasia.-Occasionally there is diffuse hypertrophy and hyperplasia of all the parathyroid tissue rather than a single or, rarely, two or more adenomata. Two types of parathyroid cells are histologically recognizable, the chief cell and the oxyphil cell. The latter contains granules. The chief cells on the other hand contain a clear cytoplasm, which may be partly or entirely vacuolated. If it is entirely vacuolated it is spoken of as a "water-clear" or "Wasserhelle" chief cell. If there is hyperplasia of these wasserhelle cells as well as the rest of the chief cells the condition is probably one of primary hyperparathyroidism and is accompanied by marked hypercalcwmia. If, on the other hand, there is no hyperplasia of the wasserhelle cells, but only of the other type of chief cell then the hyperplasia is probably secondary. Secondary hyperparathyroidism results from chronic hypocalcaemia and is usually due to advanced renal inefficiency with failure to excrete phosphate, so that the serum inorganic phosphate rises and the serum calcium falls. This provides a stimulus to the parathyroids to increase their activity in order to restore the normal balance by forcing the kidneys to excrete more phosphate and so raise the serum calcium level. These cases are often associated with long-standing azotemia and acidosis, and are properly referred to as "renal osteofibrosis" or "renal osteodystrophy". Despite the low serum calcium levels the hyperparathyroidism mobilises calcium from the bone which may show marked osteitis fibrosa with cysts, bending and fractures, and because the serum calcium level keeps low the calcium is not excreted by the kidneys, but is deposited in the tissues leading to widespread metastatic calcification. The vessels especially tend to be calcified. Another cause of low serum calcium levels is inadequate absorption of calcium from the gut, owing to vitamin D deficiency or lack of calcium in the diet or inadequate quantities to meet increased demands, as in pregnancy osteomalacia. In these cases there may be extreme demineralization of bone, but without metastatic calcification. Dr. R. R. de Mowbray:
Hypoparathyroidism
Hypoparathyroidism is supposed to be a rare disease. The post-operative form occurs in less than 1 % of patients submitted to thyroidectomy, under optimum conditions. Idiopathic hypoparathyroidism is thought to be rarer still. Only 50 or 60 proven cases have been reported in the literature. The majority of these are referred to in the articles by Drake et al. (1939) and Jordan and Kelsall (1951) . A considerable number of other cases of idiopathic tetany have been recorded, but these are not sufficiently well documented to enable us to establish the diagnosis. Of the proven cases of idiopathic hypoparathyroidism in the literature, only 3 have been reported from this country, yet we have seen 4 cases within the past two years at Guy's Hospital and other hospitals in the South East Region. The unexpected way in which these cases have presented suggests that more cases might be found if the clinical picture were more generally familiar. The following account is based on an analysis of the cases already reported in the literature, and of the four cases of which we have recently had experience in our group. A fuller account and bibliography will be published elsewhere (de Mowbray, Llewellyn-Smith and Symonds). Table I shows the chief ways in which hypoparathyroidism may present. Tetany is by far the commonest presenting symptom, but it is extremely variable in nature and severity, and may easily be mistaken for other conditions (Table II) . Epilepsy is a remarkably Though carpopedal spasms may in themselves be mistaken for focal epileptic attacks, the epileptiform convulsions are often independent of the carpopedal spasms in time of onset. Yet the epilepsy is clearly precipitated by hypocalcemia, since the fits cease to occur when the serum calcium level is restored to normal.
PRESENTING SYMPTOMS
Trophic changes.-Skin, hair and nails: The skin may be dry, rough and scaly. The hair may be generally sparse, or there may be patchy, or rarely complete, alopecia. The eyebrows and eyelashes may become thin, and there may be some loss of pubic and axillary hair. The nails may be brittle and grooved; sometimes they are grossly deformed, or they may be shed completely. A few idiopathic cases have been reported in which the skin, nails, mouth and tongue have been infected with moniliasis (Thorpe and Handley, 1929; Severinghaus, 1942; Sutphin et al., 1943; Talbot et al., 1943) .
Teeth: In cases in which the parathyroid deficiency arises in childhood, the formation of the dental roots, and of the enamel and dentine, may be interfered with, and the enamel shows transverse ridging.
Cataracts: These may occur in tetany from any cause. In hypoparathyroidism, they may develop as an early feature, even in the absence of recognized symptoms of tetany, or after the latter have been controlled by treatment.
MENTAL CHANGES
In chronic cases, anxiety symptoms, irritability and depression are liable to develop, probably as the direct result of prolongect hypocalcmemia, as well as the demoralization which results from continued spasms and fits. *The anxiety tends to lead to hyperventilation, which precipitates further tetany. Frank psychoses of manic-depressive or delusional types, have been recorded in a few cases, mainly in post-operative ones. These usually occur within a few days to a few weeks after operation and subside within a few weeks of restoring the serum calcium level to normal (Greene and Swanson, 1941; Scarlett and Houghtling, 1944; Barr et al., 1938; Eaton and Haines, 1939) .
BIOCHEMICAL CHANGES
The serum calcium level is reduced, always below 8 mg. per 100 ml., and occasionally as low as 4 to 5 mg. per 100 ml. The serum inorganic phosphate level is always raised, occasionally as high as to 10 to 12 mg. per 100 ml. There is no direct relation between the level of the serum calcium and the severity of the tetany. Severe tetany probably occurs more often in post-operative cases, in which the level falls rapidly to between 7 and 8 mg. per 100 ml.; whereas tetany may be absent, or at least very mild, in chronic cases, in the presence of levels as low as 5 to 6 mg. per 100 ml. The serum alkaline phosphatase level is usually normal or reduced. 
PATHOLOGICAL PHYSIOLOGY
The findings in hypoparathyroidism are most easily explained on the basis of Albright's theory, namely that the primary action of parathyroid hormone is to induce an increase in the urinary excretion of phosphorus. Parathyroid deficiency will therefore result in a diminished excretion of phosphate, leading to a rise in the serum phosphate level, and a compensatory fall in the serum calcium level, since the blood is fully saturated with calcium and phosphate ions; any further rise in phosphate concentration will therefore lead to supersaturation of the blood, and an increase in deposition of bone-salt (Albright and Reifenstein, 1948) . In our experience, the administration of parathyroid hormone to patients with hypoparathyroidism invariably leads to a marked increase in urinary phosphate excretion. PSEUDOHYPOPARATHYROIDISM This is a congenital disorder, first described by Albright et al. (1942) , which consists of three independent, and probably genetic, disturbances:
(1) An abnormal peripheral resistance to the action of parathyroid hormone, resulting in all the manifestations of hypoparathyroidism.
(2) A dyschondroplasia, resulting in dwarfism and in shortening of some of the metacarpals and metatarsals.
(3) A tendency to metaplastic formation of bone in the soft tissues (Elrick et al., 1950) .
Only some 17 cases have so far been reported in the literature, and only one of these from this country (Bishop and de Mowbray, 1951) . In such a case, the administration of parathyroid hormone usually fails to induce a significant increase in the excretion of phosphate in the urine.
TREATMENT
Parathormone has no place in the treatment of hypoparathyroidism. In the acute post-operative condition, symptoms can be controlled by means of calcium salts, by the intramuscular, intravenous or oral route.
In chronic cases, parathyroid hormone has 4 disadvantages:
(1) It is expensive-(2) It has to be given by injection-(3) It is liable to give rise to reactions-(4) It leads to antihormone formation-and therefore begins to lose its effect after a few weeks of continual administration.
The irradiated ergosterol derivatives are equally effective in true hypoparathyroidism and in pseudo-hypoparathyroidism. The two preparations commonly used are calciferol (vitamin D) and dihydrotachysterol (A.T.10). Both are similar in chemical structure, differing only in so far as calciferol has a double bond between the C9 and 10 atoms.
Dihydrotachysterol more closely resembles parathyroid hormone in its action, its principal effect being to stimulate the excretion of phosphate in the urine, though it increases calcium absorption from the intestine to some extent. Calciferol acts principally upon the absorption of calcium, and has also a weak action on the excretion of phosphorus in the urine, Albright et al., 1938) . There is also some evidence that calciferol and dihydrotachysterol liberate calcium from bone.
The initial dose of dihydrotachysterol is usually 3 c.c. daily, and, forcalciferol, from 200,000 to 500,000 or even a million units daily. The maintenance doses are usually from i to 1 c.c. of A. T.10 daily or from 50,000 to 200,000 units of calciferol daily. Dihydrotachysterol is theoretically preferable, in so far as it more closely resembles parathyroid hormone in its action. Calciferol has the advantage that it is much cheaper. An average maintenance dose of dihydrotachysterol (0 5 c.c. daily) costs approximately£1 per month, whereas a corresponding dose of vitamin D (100,000 units daily} costs only about a shilling per month.
As far as their effects in controlling the symptoms and the serum calcium level are concerned, there seems to be little to choose between them. Probably calciferol is more likely to lead to hypercalcwmia, in view of the fact that it acts predominantly upon calcium absorption and has a cumulative action in this respect. Though hypercalcamia is a well-known complication of the use of high doses of calciferol in skin disorders, I have been able to find only one case of hypoparathyroidism in which acute hypercalcemia with toxic effects resulted from this treatment, and the dose in this case was no higher than 300,000 units daily (Howard and Meyer, 1948) . We recently had experience of another case, in a woman aged 48 years with longstanding post-operative hypoparathyroidism and hypertension, on a dose of 200,000 units daily. Acute hypercalcmmia is probably due either to an individual idiosyncrasy to calciferol or to impaired renal function. No serious effects seem to have been reported from treatment with dihydrotachysterol.
-The Sulkowitch reaction is a useful practical guide to treatment, but is not sufficiently reliable in itself. We have found it necessary to ask for repeated estimations of the serum calcium level. The serum calcium level may be low, when the calcium reaction in the urine is apparently optimal, and, in the case of acute hypercalcxemia of which we recently had experience, there was no excess of calcium in the urine.
Nevertheless, the Sulkowitch reaction has the great virtue that the patient can carry it out himself, and that a heavy calcium precipitate will warn him to reduce the dose, or to stop taking the drug, and see his physician immediately, while an absence of any precipitate will indicate the need for an increase in the dose.
The treatment of hypoparathyroidism is not always easy. Dosage may have repeatedly to be readjusted in response to infections or according to mental and physical stresses and strains. The problem is in fact comparable to that of the treatment of diabetes mellitus.
We do not consider that it is necessary to place the patients on a strict diet. A high calcium, low phosphorus diet, will restore the serum calcium and phosphorus levels to normal (Anderson and Lyall, 1939) but it is unlikely that a patient will be able to adhere to such a diet with sufficient accuracy. It is, however, advisable to avoid excess of milk, in view of the fact that it has a high content of phosphorus, as well as being rich in calcium.
Nor do we find it necessary to administer calcium salts, and it seems simpler to have only one variable to contend with when one is adjusting the dose of calciferol or A. T.10. CONCLUSIONS Hypoparatlhyroidism is generally regarded as a rare disorder. More cases might come to light, however, if the diagnosis were considered in patients presenting with parrsthesir, pains, cramps and spasms in the extremities, in cases of epilepsy, and of cataracts occurring in young people. Cases associated with trophic changes in the skin, hair and nails might be found in Skin Clinics. Threequarters of the cases of idiopathic hypoparathyroidism reported in the literature have had their onset of symptoms in childhood, and the diagnosis should be considered in cases of infantile convulsions.
The majority of cases are not referred to endocrinologists in the first instance, but we should do well to draw the attention of our colleagues in other special departments to this condition, and thus stimulate a search for further cases. Dr. A. B . Anderson asked if the varying chemical picture in hyperparathyroidism could be due to variation in the length of time that this comparatively chronic disease had been present. He also asked if anything was known of the geographical distribution of hyperparathyroidism. The disease appeared to be more prevalent in America than in this country. In Glasgow, where all sorts of bone disease was very prevalent, he had only seen one case during ten years at the Glasgow Royal Infirmary, although the clinicians were looking for it, especially in patients attending the urological clinic. Dr. R. V. Coxon: While it is true that Dr. Albright has attached great importance to the renal side of parathyroid action, it should, I think, be recalled that he did himself initiate some experiments on nephrectomized rats which demonstrated by histological criteria that direct effects on bone can be produced with parathormone, and this finding is duly mentioned in his book. Admittedly it there follows the exposition of his main thesis concerning the renal action of the hormone, but readers of the book are warned in the preface that the writer's hypotheses are subject to change without notice (Albright and Reifenstein, 1948) .
The divergent results obtained with injections of parathormone in normal human subjects aredisturbing and raise the possibility that some long-term adaptive response to variation in dietary habits may perhaps play a part in accounting for discrepant effects in different centres at different are invoked by Snapper (1949) in explanation of the variable incidence of the different clinical types. of hyperparathyroidism in different parts of the world. mEq./l.
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Comment.
-Case I shows that a patient may go through pregnancy, whilst in a state of chronic hypocalcmmia due to incomplete correction of her hypoparathyroidism, without apparent ill-effects to herself or her child. It remains to be seen whether the dosage of vitamin D which was insufficient during pregnancy will restore the serum calcium and maintain a normal level. Case II shows the rapidity with which hypercalcaemia may develop, and the need to control carefully any change in treatment of a case of hypoparathyroidism. Dr. C. E. Dent, in reply: There is good evidence that the amount of renal failure present varies with .the length of time the disease has been present. This changes the chemical picture to the extent that the blood phosphorus is higher than expected and the hypercalciuria reduced, apart, of course, from the other better-known signs of renal failure. The main diagnostic difficulty arises in cases where there is only a minimal rise in blood calcium (11 5 mg. % or so). I do not think this is related to duration of the disease. I do not think there is any reason to believe yet in a geographical distribution ofhyperparathyroidism. The main factor in the frequency of diagnosis is that clinicians should be looking for it. It was a very rare disease in University College Hospital before 1949. In the last two to three years we have had 7 cases proved at operation with another almost certain one waiting to come in. 6 of these 8 came to us in the ordinary way through our out-patient departments, the other 2 were referred from other hospitals with the diagnosis already suspected.
I entirely agree with Dr. Coxon's remarks. Dr. Albright has recently cast doubts about his previous views on the renal action of parathormone (Address to New York Academy of Medicine, October 6, 1952: "Hormones and common sense"). I think the divergent results with parathormone injections are more likely to be due to differences in the extract. This is very crude indeed. I was intrigued that Dr. Baron has noted signs of vitamin-D intoxication coming on rapidly and unexpectedly. Dr. W. R. Trotter and I recently encountered 4 such cases within a short time of each other. We have been quite unable to account for this coincidence. The manufacturers are insistent that the product is stable and adequately standardized. We have recently recovered entire particles of calciferol tablets from the stools of a patient being treated with large doses. It may be that the dose is not always absorbed. Sometimes the tablet is made up, without any indication on the label, with calcium phosphate which probably increases its action. I have used both A.T.10 and calciferol. A point not usually stressed is the more rapid action of A.T.10 in elevating the blood calcium. This makes it easier to use in determining the correct maintenance dose of a new patient. It is, however, not a pure chemical substance and has to be standardized biologically. It is our strong impression that batches vary in potency, In one case at least a batch was clearly proved (and confirmed by the manufacturers, who recalled it) to be below strength. Even more embarrassment was caused us on the two recent occasions when the supply of A.T.10 Shorthand typist, aged 17 years, referred to hospital on 22.4.52 because she had never menstruated, and there was a complete absence of pubic and axillary hair, but normal breast development. Patient a twin-other twin died in utero. Family history of late menarche. Normal stature with well developed breasts) normal blonde head of hair (Fig. 1) . No axillary or pubic hair, and skin generally somewhat hairless. Vulva infantile, but otherwise appeared normal. Vagina only half an inch in length. On rectal examination, no internal female organs palpated. No abnormal signs heart, lungs, abdomen, and C.N.S.
Blood pressure 130/90. Urine normal. X-ray sella turcica normal. 17-ketosteroids 8-9 mg. per twenty-four hours.
She has the mental attitudes of a girl. Socially and occupationally, the adaptation is that of a girl of 17 of rather above average intelligence. Sexually, she is a little immature, but her inclinations are entirely female. She has had girls' toys, has female daydreams, reads love stories, and identifies herself with female fictional and film characters-she hopes to marry and is fond of babies.
Laparotomy: There was no uterus, but a broad fold of peritoneum running across the pelvis in the corresponding position. On the left side, lying on the psoas muscle, was a gonad anatomically resembling a testis. On the right side, a similar structure was found, but more inferiorly placed so that it was lying right at the internal ring. The arrangement was entirely consistent with undescended testes. Both inguinal regions were bimanually palpated, and no swelling noted in either groin. The broad fold of peritoneum running across the pelvis is the transverse pelvic fold, a remnant of the uro-rectal septum or genital fold, and its attachment to the inguinal fold (gubernaculum) appears almost ligamental, and may well have been a factor in checking the descent of the testis. Such an attachment as this occurs in the female from the lateral aspect of the body of the uterus to the ovary to form the ligament of the ovary (Fig. 2) .
